Related Experiment Videos
["Sentinel" lymph node biopsy in breast carcinoma. Current experiences].
A Bembenek1, C Kettelhack, T Reuhl
1Klinik für Chirurgie und Chirurgische Onkologie, Robert-Rössle-Klinik, Charité, Campus Berlin-Buch, Humboldt-Universität zu Berlin. bembenek@rrk-berlin.de
Zentralblatt Fur Chirurgie
|December 1, 2000
Summary
Sentinel lymph node biopsy (SNB) is a reliable method for determining nodal status in early breast cancer patients up to 3 cm. This technique can help avoid unnecessary surgeries and improve detection rates, especially with immunohistochemistry.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Sentinel lymph node biopsy (SNB) is increasingly utilized for nodal staging in breast cancer.
- Accurate nodal status determination is crucial for treatment planning and prognosis.
Purpose:
- To evaluate the efficacy and accuracy of SNB using a radionuclide method over a 3-year period in breast cancer patients.
- To assess the impact of tumor size on SNB detection and prediction accuracy.
Summary:
- The study involved 146 breast cancer patients undergoing SNB via a radionuclide method.
- Detection and accuracy rates varied with tumor size, with higher success in smaller tumors (<3 cm).
- SNB accurately predicted nodal status in early-stage breast cancer, with immunohistochemistry identifying additional positive cases.
Impact:
- SNB can potentially spare approximately 50% of patients from extensive axillary surgery.
- Immunohistochemical staining of sentinel nodes can identify additional micrometastases, improving staging accuracy.
- The SNB method shows promise for identifying parasternal metastasis and can be applied in specific patient subgroups, including those with recurrent disease or after neoadjuvant therapy.